版本:
中国

BRIEF-Paratek Pharma, Zai Lab announce agreement

April 24 Paratek Pharmaceuticals Inc:

* Paratek Pharmaceuticals and Zai Lab announce collaboration, development and license agreement for omadacycline in China

* Paratek Pharmaceuticals Inc - under deal, co granted to Zai Lab exclusive license to develop, manufacture, commercialize omadacycline

* Paratek Pharmaceuticals Inc - deal terms covers territories for omadacycline for Greater China Territory, Hong Kong, Macau, and Taiwan markets

* Paratek Pharmaceuticals Inc - companies will establish joint steering committee to review, oversee all development, manufacturing, commercialization plans

* Paratek Pharmaceuticals Inc - Paratek will receive a $7.5 million upfront payment in connection with signing of agreement

* Paratek Pharmaceuticals Inc - Allergan has publicly announced plans to submit an NDA in U.S. In second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐